Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development
This dissertation centers on the study of epithelial to mesenchymal cell transition (EMT) in the heart model of valve development. EMT is a process used by specific cells to invade adjacent matrix in order to differentiate into a three-dimensional structure. The first section of the project includ...
Main Author: | |
---|---|
Other Authors: | |
Language: | en |
Published: |
The University of Arizona.
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/217109 |
id |
ndltd-arizona.edu-oai-arizona.openrepository.com-10150-217109 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-arizona.edu-oai-arizona.openrepository.com-10150-2171092015-10-23T04:52:50Z Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development Lencinas Sanabria, Alejandro Runyan, Raymond B. Camenisch, Todd D. Regan, John W. Lantz, Robert Clark Runyan, Raymond B. Collagen Gel EMT checkpoint Heart valve formation Olfactomedin-1 Pharmacology & Toxicology Arsenic Cancer metastasis This dissertation centers on the study of epithelial to mesenchymal cell transition (EMT) in the heart model of valve development. EMT is a process used by specific cells to invade adjacent matrix in order to differentiate into a three-dimensional structure. The first section of the project includes a study on the effects of inorganic arsenic on EMT and therefore the environmental concerns produced by deleterious effects on EMT. The second section focuses on the discovery of an intrinsic regulator of EMT, olfactomedin-1 (OLFM1). The discovery of a novel regulator of EMT in the atrioventricular canal is interesting, by itself, as it allows us to better understand the intrinsic molecular regulation of EMT in valve formation of the heart. The activity of this protein, as a regulator of cell invasion, identifies an important checkpoint in EMT. Because OFLM1 is conserved across many species, including humans, it may be a common or shared regulator of all types of EMT including cancer. Therefore, OLFM1 represents a promising new target for an anti-cancer agent as well as a potential clinical inducer of EMT to repair congenital heart disease that include valve defects. 2012 text Electronic Dissertation http://hdl.handle.net/10150/217109 en Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. The University of Arizona. |
collection |
NDLTD |
language |
en |
sources |
NDLTD |
topic |
Collagen Gel EMT checkpoint Heart valve formation Olfactomedin-1 Pharmacology & Toxicology Arsenic Cancer metastasis |
spellingShingle |
Collagen Gel EMT checkpoint Heart valve formation Olfactomedin-1 Pharmacology & Toxicology Arsenic Cancer metastasis Lencinas Sanabria, Alejandro Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
description |
This dissertation centers on the study of epithelial to mesenchymal cell transition (EMT) in the heart model of valve development. EMT is a process used by specific cells to invade adjacent matrix in order to differentiate into a three-dimensional structure. The first section of the project includes a study on the effects of inorganic arsenic on EMT and therefore the environmental concerns produced by deleterious effects on EMT. The second section focuses on the discovery of an intrinsic regulator of EMT, olfactomedin-1 (OLFM1). The discovery of a novel regulator of EMT in the atrioventricular canal is interesting, by itself, as it allows us to better understand the intrinsic molecular regulation of EMT in valve formation of the heart. The activity of this protein, as a regulator of cell invasion, identifies an important checkpoint in EMT. Because OFLM1 is conserved across many species, including humans, it may be a common or shared regulator of all types of EMT including cancer. Therefore, OLFM1 represents a promising new target for an anti-cancer agent as well as a potential clinical inducer of EMT to repair congenital heart disease that include valve defects. |
author2 |
Runyan, Raymond B. |
author_facet |
Runyan, Raymond B. Lencinas Sanabria, Alejandro |
author |
Lencinas Sanabria, Alejandro |
author_sort |
Lencinas Sanabria, Alejandro |
title |
Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
title_short |
Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
title_full |
Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
title_fullStr |
Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
title_full_unstemmed |
Arsenic and Olfactomedin-1 Regulation of Epithelial to Mesenchymal Cell Transition (EMT) in Heart Valve Development |
title_sort |
arsenic and olfactomedin-1 regulation of epithelial to mesenchymal cell transition (emt) in heart valve development |
publisher |
The University of Arizona. |
publishDate |
2012 |
url |
http://hdl.handle.net/10150/217109 |
work_keys_str_mv |
AT lencinassanabriaalejandro arsenicandolfactomedin1regulationofepithelialtomesenchymalcelltransitionemtinheartvalvedevelopment |
_version_ |
1718100977309974528 |